SSY GROUP: Benzenesulfonic Acid Amlodipine Tablets Obtained Drug Production Registration Approval
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, SSY GROUP announced that it has obtained the drug production registration approval from the National Medical Products Administration of China for Amlodipine Besylate Tablets (5mg and 2.5mg), which are classified as Category 4 chemical drugs and are considered to have passed the consistency evaluation. Amlodipine Besylate Tablets are primarily used for the treatment of hypertension, chronic stable angina, and vasospastic angina, and can be used alone or in combination with other medications
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments